Repurposing the DNA Labeling Agent EdU for Therapy Against Heterogeneous Patient Glioblastoma.
March 25, 2025
Kaanoglu H, Adefolaju A, Fraley C, Shobande M, Dasari R, Mann B, Bell N, Keir ST, Higgins D, Kram DE, Hingtgen SD, Sancar A, Satterlee AB.Mol Cancer Ther. 2025 Mar 25. doi: 10.1158/1535-7163.MCT-24-1098. Online ahead of print.PMID: 40130554